LG100268
LG100268 is a potent, selective, and orally active retinoid X receptor (RXR) agonist with nanomolar activity against RXR-α, -β, and -γ. It has been used in research to study adipocyte differentiation, sexual differentiation in fish models, and modulation of PD-L1 in breast cancer cell lines, demonstrating utility in metabolic and oncology studies.
Product Specifications
CAS Number
153559-76-3
Product Name Alternative
LG 100268, LG100268, LG-100268, LGD1268, LGD 1268, LG268, ALRT 268
Field of Research
Cell Biology, Immunology & Inflammation, Metabolism Research
Purity
99.83% (May vary between batches)
Solubility
DMSO:4 mg/mL (11 mM)
Smiles
O=C (O) C1=CN=C (C=C1) C2 (C=3C=C4C (=CC3C) C (C) (C) CCC4 (C) C) CC2
Molecular Formula
C24H29NO2
Molecular Weight
363.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
035798 200 µL
FUT11, ID (FUT11, Alpha- (1,3) -fucosyltransferase 11, Fucosyltransferase XI, Galactoside 3-L-fucosyltransferase 11)
Sign In for Pricing
View Details bs-2696R-BF680-TR 20 µL
S100-A8 / MRP8 Polyclonal Antibody, AbBy Fluor™ 680 Conjugated
Sign In for Pricing
View Details 